Outcomes for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the elderly

Beaujard, 2000, Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis, Cancer, 88, 2512, 10.1002/1097-0142(20000601)88:11<2512::AID-CNCR12>3.0.CO;2-J Glehen, 2004, Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia, Lancet Oncol, 5, 219, 10.1016/S1470-2045(04)01425-1 Verwaal, 2008, 8-Year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer, Ann Surg Oncol, 15, 2426, 10.1245/s10434-008-9966-2 Glehen, 2004, Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study, J Clin Oncol, 22, 3284, 10.1200/JCO.2004.10.012 Verwaal, 2005, Long-term survival of peritoneal carcinomatosis of colorectal origin, Ann Surg Oncol, 12, 65, 10.1007/s10434-004-1167-z Sugarbaker, 1999, Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy, Ann Surg Oncol, 6, 727, 10.1007/s10434-999-0727-7 Sugarbaker, 2006, Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy, Ann Surg Oncol, 13, 635, 10.1245/ASO.2006.03.079 Smeenk, 2007, Learning curve of combined modality treatment in peritoneal surface disease, Br J Surg, 94, 1408, 10.1002/bjs.5863 Levine, 2007, Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures, J Am Coll Surg, 204, 943, 10.1016/j.jamcollsurg.2006.12.048 Gusani, 2008, Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center, Ann Surg Oncol, 15, 754, 10.1245/s10434-007-9701-4 Saxena, 2010, Critical assessment of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei, Ann Surg Oncol, 17, 1291, 10.1245/s10434-009-0875-9 Elias, 2010, Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study, J Clin Oncol, 28, 63, 10.1200/JCO.2009.23.9285 Jacquet, 1996, Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis, Cancer Treat Res, 82, 359, 10.1007/978-1-4613-1247-5_23 Jacquet, 1996, Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis, 359 Clavien, 2009, The Clavien-Dindo classification of surgical complications: five-year experience, Ann Surg, 250, 187, 10.1097/SLA.0b013e3181b13ca2 Koppe, 2006, Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies, Ann Surg, 243, 212, 10.1097/01.sla.0000197702.46394.16 Pelz, 2010, Evaluation of best supportive care and systemic chemotherapy as treatment stratified according to theretrospective peritoneal surface disease severity score (PSDSS) for peritoneal carcinomatosis of colorectal origin, BMC Cancer, 10, 689, 10.1186/1471-2407-10-689 Melis, 2012, 14(9), 583 Fong, 1995, Pancreatic or liver resection for malignancy is safe and effective for the elderly, Ann Surg, 222, 426, 10.1097/00000658-199522240-00002 Mueller, 2008, Cytoreductive surgery in the elderly patients–is it feasible?, Hepatogastroenterology, 55, 2005 Baratti, 2012, Identification of a subgroup of patients at highest risk for complications after surgical cytoreduction and hyperthermic intraperitoneal chemotherapy, Ann Surg, 256, 334, 10.1097/SLA.0b013e31825704e3